David Michael Johnson, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 25,794 shares at $43.50 ($1.1M) on 2021-04-05, disclosed to the SEC on 2021-04-05.
Open-market sale of $1.1M ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.50 | 12,897 | $561K | 50.0% |
| 2 | $43.50 | 12,897 | $561K | 50.0% |
| Total | $43.50 avg | 25,794 | $1.1M | 100% |
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |